Literature DB >> 20215705

HDL/apolipoprotein A-I binds to macrophage-derived progranulin and suppresses its conversion into proinflammatory granulins.

Hanayuki Okura1, Shizuya Yamashita, Tohru Ohama, Ayami Saga, Aya Yamamoto-Kakuta, Yoko Hamada, Nagako Sougawa, Reiko Ohyama, Yoshiki Sawa, Akifumi Matsuyama.   

Abstract

AIM: HDL has anti-inflammatory effects on macrophages, although the mechanism of action remains unclear. We hypothesized that HDL suppresses the conversion of macrophage-secreted factors into proinflammatory factors via binding, and tried to identify the factor that could form a complex with HDL and/or apolipoprotein (apo) A-I. METHODS AND
RESULTS: In conditioned media obtained from human monocyte-derived macrophages, we found an apo A-I binding protein and identified the protein as progranulin/proepithelin/acrogranin/PCDGF. Co-immunoprecipitation analysis showing that progranulin binds and forms a complex with apo A-I and the presence of progranulin in the HDL fraction in the sera indicated that progranilin is a novel apolipoprotein. Conditioned media of HEK293 cells transfected with progranulin augmented the expression of TNF-alpha and IL-1-beta on macrophages, but these effects of progranulin were inhibited by co-incubation with HDL or apo A-I. Anti-progranulin antibodies also reduced the expression of TNF-alpha and IL-1-beta on macrophages. Granulins as conversion products derived from progranilin increased TNF-alpha and IL-1-beta expression and the effects were not suppressed by HDL.
CONCLUSIONS: Our results suggest that the anti-inflammatory effects of HDL on macrophages might be due to suppression of the conversion of progranulin into proinflammatory granulins by forming a complex.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20215705     DOI: 10.5551/jat.3921

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  40 in total

1.  Osteocytes control myeloid cell proliferation and differentiation through Gsα-dependent and -independent mechanisms.

Authors:  Ehab Azab; Kevin Brown Chandler; Yuhei Uda; Ningyuan Sun; Amira Hussein; Raghad Shuwaikan; Veronica Lu; Catherine E Costello; Mark E McComb; Paola Divieti Pajevic
Journal:  FASEB J       Date:  2020-06-18       Impact factor: 5.191

Review 2.  Progranulin: a growth factor, a novel TNFR ligand and a drug target.

Authors:  Chuan-ju Liu; Xavier Bosch
Journal:  Pharmacol Ther       Date:  2011-10-08       Impact factor: 12.310

Review 3.  Potential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairment.

Authors:  Hyeon-Sook Suh; Benjamin B Gelman; Sunhee C Lee
Journal:  J Neuroimmune Pharmacol       Date:  2014-03       Impact factor: 4.147

Review 4.  Cellular effects of progranulin in health and disease.

Authors:  Louis De Muynck; Philip Van Damme
Journal:  J Mol Neurosci       Date:  2011-05-25       Impact factor: 3.444

Review 5.  Progranulin and its biological effects in cancer.

Authors:  Fabian Arechavaleta-Velasco; Carlos Eduardo Perez-Juarez; George L Gerton; Laura Diaz-Cueto
Journal:  Med Oncol       Date:  2017-11-07       Impact factor: 3.064

Review 6.  Progranulin: a promising therapeutic target for rheumatoid arthritis.

Authors:  Chuan-ju Liu
Journal:  FEBS Lett       Date:  2011-05-04       Impact factor: 4.124

Review 7.  Structure, function, and mechanism of progranulin; the brain and beyond.

Authors:  Huishi Toh; Babykumari P Chitramuthu; Hugh P J Bennett; Andrew Bateman
Journal:  J Mol Neurosci       Date:  2011-06-21       Impact factor: 3.444

8.  Progranulin Controls Sepsis via C/EBPα-Regulated Il10 Transcription and Ubiquitin Ligase/Proteasome-Mediated Protein Degradation.

Authors:  Wenjun Yan; Aihao Ding; Ha-Jeong Kim; Hua Zheng; Fang Wei; Xiaojing Ma
Journal:  J Immunol       Date:  2016-09-12       Impact factor: 5.422

Review 9.  Progranulin: an emerging target for FTLD therapies.

Authors:  Jennifer Gass; Mercedes Prudencio; Caroline Stetler; Leonard Petrucelli
Journal:  Brain Res       Date:  2012-01-28       Impact factor: 3.252

10.  Secreted progranulin is a homodimer and is not a component of high density lipoproteins (HDL).

Authors:  Andrew D Nguyen; Thi A Nguyen; Basar Cenik; Gang Yu; Joachim Herz; Tobias C Walther; W Sean Davidson; Robert V Farese
Journal:  J Biol Chem       Date:  2013-01-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.